文献速递肝病

2008至2022年美国肝硬化成人急诊就诊利用与结局

Emergency Department Utilization and Outcomes Among Adults With Cirrhosis From 2008 to 2022 in the United States.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-08-23

基于2008至2022年Optum去标识化数据库分析198,439例肝硬化患者,其年龄标化每人年急诊就诊次数为1.72次,高于无肝硬化者的0.46次、充血性心力衰竭的1.66次和慢性阻塞性肺疾病的1.22次;年龄标化90天死亡率为12.2%,高于无肝硬化者的4.8%、充血性心力衰竭的6.9%和慢性阻塞性肺疾病的6.3%。

要点

  • 肝硬化患者年龄标化每人年急诊就诊次数为1.72次,无肝硬化为0.46次。
  • 肝硬化患者年龄标化90天死亡率为12.2%,无肝硬化为4.8%。
  • 急诊就诊后30天内无任何门诊随访者90天死亡率为22.0%,高于同时有初级保健和消化科/肝病科随访者的7.9%。

核心结论

  • 肝硬化患者急诊利用率和急诊就诊后死亡率高于充血性心力衰竭和慢性阻塞性肺疾病,这些发现为开展基于急诊的干预以改善肝硬化相关结局提供了动力。

研究设计与样本

  • 分析Optum去标识化Clinformatics Data Mart数据库2008至2022年数据,纳入至少180天入组的成人,肝移植受者于移植当年删失。
  • 共纳入38,419,650例患者,其中198,439例为肝硬化患者(中位年龄66岁,四分位距57-72岁;54%男性;62%白人)。
  • 急诊就诊按肝脏相关与非肝脏相关分层,使用经验证的计费代码定义识别;采用线性回归评估每年急诊就诊次数,采用逻辑回归评估90天死亡率和出院去向,模型调整患者和就诊层面特征。

主要发现

  • 年龄标化分析中,肝硬化患者每人年急诊就诊次数为1.72次(95%CI 1.71-1.74),无肝硬化者为0.46次(95%CI 0.46-0.46),充血性心力衰竭为1.66次(95%CI 1.66-1.66),慢性阻塞性肺疾病为1.22次(95%CI 1.22-1.22)。
  • 年龄标化90天死亡率肝硬化患者为12.2%(95%CI 12.1%-12.4%),无肝硬化者为4.8%(95%CI 4.8%-4.8%),充血性心力衰竭为6.9%(95%CI 6.9%-6.9%),慢性阻塞性肺疾病为6.3%(95%CI 6.3%-6.4%)。
  • 在代偿期肝硬化患者中,非肝脏相关急诊就诊导致出院回家的比例为52.8%(95%CI 52.2%-53.5%),高于肝脏相关急诊就诊的39.2%(95%CI 38.5%-39.8%);在失代偿期肝硬化患者中,非肝脏相关急诊就诊导致出院回家的比例为42.2%(95%CI 41.5%-42.8%),高于肝脏相关急诊就诊的29.5%(95%CI 29.0%-30.1%)。
  • 探索性分析中,急诊出院后30天内仍存活且未再住院的患者里,无任何门诊随访者90天死亡率为22.0%(95%CI 21.0%-23.0%),高于30天内同时有初级保健和消化科/肝病科随访者的7.9%(95%CI 7.3%-8.5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Globally, emergency departments (ED) are experiencing rising costs and crowding. Despite its importance, ED utilization and outcomes among patients with cirrhosis are understudied. METHODS: We analyzed Optum's de-identified Clinformatics Data Mart Database, between 2008 and 2022, including adults with at least 180 days of enrollment. Liver transplant recipients were censored at the year of transplant. ED visits (stratified by liver vs non-liver related) were identified using validated billing code definitions. Linear regression was used to assess ED visits per year, and logistic regression was used to assess 90-day mortality rates and discharge dispositions, with models adjusted for patient- and visit-level characteristics. RESULTS: Among 38,419,650 patients, 198,439 were with cirrhosis (median age, 66 [interquartile range, 57-72 years]; 54% male; 62% White). In age-adjusted analysis, ED visits per person-year were 1.72 (95% confidence interval [CI], 1.71-1.74) with cirrhosis vs 0.46 (95% CI, 0.46-0.46) without cirrhosis, 1.66 (95% CI, 1.66-1.66) for congestive heart failure (CHF), and 1.22 (95% CI, 1.22-1.22) for chronic obstructive pulmonary disease (COPD). Age-adjusted 90-day mortality rates were 12.2% (95% CI, 12.1%-12.4%) with cirrhosis vs 4.8% [95% CI, 4.8%-4.8%) without cirrhosis, 6.9% (95% CI, 6.9%-6.9%) for CHF, and 6.3% (95% CI, 6.3%-6.4%) for COPD. Non-liver (vs liver-related) ED visits were more likely to lead to discharge home among patients with compensated (52.8%; 95% CI, 52.2%-53.5% vs 39.2%; 95% CI, 38.5%-39.8%) and decompensated (42.2%; 95% CI, 41.5%-42.8% vs 29.5%; 95% CI, 29.0%-30.1%) cirrhosis. In exploratory analysis, among patients who remained alive and were not readmitted for 30 days after ED discharge, those without any outpatient follow-up had higher 90-day mortality (22.0%; 95% CI, 21.0%-23.0%) than those with both primary care and gastroenterology/hepatology follow-up within 30-days (7.9%; 95% CI, 7.3%-8.5%). CONCLUSIONS: Patients with cirrhosis have higher ED utilization and almost 2-fold higher post-ED visit mortality than CHF and COPD. These findings provide impetus for ED-based interventions to improve cirrhosis-related outcomes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Elhence H, Dodge JL, Flemming JA, et al. Emergency Department Utilization and Outcomes Among Adults With Cirrhosis From 2008 to 2022 in the United States. Clin Gastroenterol Hepatol. 2024. PMID: 39181424. doi:10.1016/j.cgh.2024.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。